Intuitive Surgical Strengthens European Foothold with Direct Distribution Shift

Intuitive Surgical acquires key sales divisions, ending its distributor model in Southern Europe to directly manage systems and support for over 470 da Vinci and Ion platforms.

The robotic surgery leader Intuitive Surgical has moved to take full control of its commercial operations across Southern Europe. In a strategic pivot from its previous distributor-led model, the company has completed the acquisition of key sales divisions from regional partners, including ab medica and Abex. This transition, finalized on March 1, 2026, now places the direct management of systems in Italy, Spain, Portugal, and adjacent territories under Intuitive’s own organization.

Driving Growth Through Direct Customer Relationships

Management views this structural shift as essential for accelerating the adoption of minimally invasive surgical techniques in the region. By bringing over 470 installed surgical systems under its direct purview, Intuitive Surgical aims to provide more agile support to hospital clients. Approximately 250 employees from the former distributors have joined the U.S. corporation to ensure local, hands-on service.

Chief Executive Officer Dave Rosa emphasized that a direct operational presence is crucial for better understanding and meeting the specific needs of European clinics. The move is designed to scale access to advanced surgical technology more effectively across the continent.

Enhancing Recurring Revenue Streams

Beyond strengthening customer ties, the new integrated structure grants the company greater command over its high-margin service and consumables business. This includes not only the well-established da Vinci surgical system but also the newer Ion platform for lung biopsies, which recently launched in both Italy and Spain. Eliminating intermediary distributors allows Intuitive to manage the sales of instruments, accessories, and maintenance services with improved efficiency.

Market Performance and Strategic Context

On the trading floor, Intuitive Surgical’s shares experienced muted activity, edging down by 0.69 percent to €421.55. This movement extends the stock’s year-to-date trend, which currently shows a decline of approximately 12 percent since the beginning of the year.

The integration of Southern European markets represents a key step in solidifying the company’s overall European strategy. By overseeing the entire lifecycle of its systems—from initial placement to daily operational supplies—Intuitive Surgical gains enhanced revenue predictability in these important markets. The operational rollout of the Ion platform under direct management will be a significant indicator of the expansion's success in the coming quarters.